GLYRX-PF (GLYCOPYRROLATE) — FDA Approval NDA210997 (EXELA PHARMA)
GLYRX-PF (GLYCOPYRROLATE) — FDA Approval NDA210997 (EXELA PHARMA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: GLYRX-PF; Active ingredients: GLYCOPYRROLATE; Application number: NDA210997.
| Brand name | GLYRX-PF |
|---|---|
| Active ingredients | GLYCOPYRROLATE |
| Application number | NDA210997 |
| Sponsor | EXELA PHARMA |
| Dosage form | SOLUTION |
| Route | INTRAMUSCULAR, INTRAVENOUS |
| Marketing status | Prescription |
| Products in application | 4 |
| First approval date | 20180711 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →